The trajectory of companies tied to Viagra's legacy presents a complex investment picture . While the initial success generated substantial gains, generic copies have significantly diminished revenue. Investing in related pharmaceutical businesses now requires a careful assessment of intellectual property protection , evolving healthcare changes, a